MobiHealth News October 5, 2021
The funding will help the company grow its team and go through clinical trials.
GraphWear announced Monday it raised $20.5 million in Series B funding for its needle-free continuous glucose monitoring platform.
The round was led by Mayfield, with participation from MissionBio Capital, Builders VC and VSC Ventures.
WHAT IT DOES
The startup makes a wearable sensor that it claims can measure glucose molecules on the surface of the skin and provide a read of glucose levels without drawing blood.
“With GraphWear, we’ve sought to design a non-invasive solution, with low power requirements and a small form factor that opens up potential for monitoring health on a global scale,” president and cofounder Rajatesh Gudibande said in a statement.
“Through our...
Today's Sponsors
Today's Sponsor